Judging the Abortion Pill | California Healthline

The Host

Julie Rovner
KHN

@jrovner

Learn Julie’s tales.

Julie Rovner is leader Washington correspondent and host of KHN’s weekly well being coverage information podcast, “What the Well being?” A famous skilled on well being coverage problems, Julie is the creator of the seriously praised reference e book “Well being Care Politics and Coverage A to Z,” now in its 3rd version.

This week, the eyes of the country are on Texas, the place a federal pass judgement on who previously labored for a conservative Christian advocacy team is ready to come to a decision whether or not the abortion capsule mifepristone can keep available on the market. Mifepristone is part of a two-pill routine that now accounts for greater than part of the abortions in america.

In the meantime, Novo Nordisk, any other of the 3 huge drug firms that dominate the marketplace for diabetes remedies, has introduced it’ll lower the cost of a lot of its insulin merchandise. Eli Lilly introduced its cuts early this month. However the push for extra inexpensive insulin from activists and individuals of Congress isn’t the one reason why for the exchange: On account of quirks in the best way the drug marketplace works, reducing costs may in truth save the corporations money in the end.

This week’s panelists are Julie Rovner of KHN, Jessie Hellmann of CQ Roll Name, Sarah Karlin-Smith of the Crimson Sheet, and Alice Miranda Ollstein of Politico.

Panelists

Jessie Hellmann
CQ Roll Name

@jessiehellmann

Learn Jessie’s tales

Sarah Karlin-Smith
Crimson Sheet

@SarahKarlin

Learn Sarah’s tales

Alice Miranda Ollstein
Politico

@AliceOllstein

Learn Alice’s tales

A number of the takeaways from this week’s episode:

• The federal pass judgement on analyzing the decades-old approval of mifepristone may factor a choice at any time after a listening to in large part in the back of closed doorways, all the way through which he seemed open to proscribing get admission to to the drug.
• Democratic governors search to counter the coolness of Republican states’ warnings to pharmacies about distributing mifepristone, and a separate lawsuit in Texas seeks to set a precedent for punishing individuals who aren’t scientific suppliers for helping anyone in acquiring an abortion.
• In pandemic information, Congress is shifting ahead with law that will drive the Biden management to declassify intelligence associated with the origins of covid-19, whilst the editor of Cochrane Opinions posted a explanation of its not too long ago printed protecting learn about, noting it’s “misguided” to mention it discovered that mask don’t seem to be efficient.
• Most sensible federal well being officers despatched an atypical letter to Florida’s surgeon normal, caution that his include of vaccination incorrect information is destructive, even fatal, to American citizens. Whilst covid vaccines include some possibility of adverse well being results, contracting covid carries the next possibility of deficient results.
• Novo Nordisk’s announcement that it’ll lower insulin costs places drive on Sanofi, the rest insulin maker that has but to regulate its costs.
• The Veterans Well being Management will quilt Leqembi, a brand new Alzheimer’s drug. The verdict comes as Medicare considers whether or not it’ll additionally quilt the drug. Professionals warning that new medicine shaking up the weight-loss marketplace may turn out expensive for Medicare.
• Washington is eyeing adjustments to federal laws that will have an effect on the follow of drugs. One exchange would drive well being plans to hurry up “prior authorization” selections by means of well being insurers and build up transparency round denials, which supporters say would lend a hand sufferers higher get admission to wanted care. Some other proposal would ban noncompete clauses in contracts, together with in well being care. Arguments for and towards the exchange each cite the problem of doctor burnout — despite the fact that they disagree on whether or not the ban would make the issue higher or worse.

Plus, for “further credit score,” the panelists counsel well being coverage tales they learn this week that they suspect you will have to learn, too:

Julie Rovner: “Tradeoffs” podcast’s “The Conservative Conflict Over Abortion Bans,” by means of Alice Miranda Ollstein and Dan Gorenstein

Alice Miranda Ollstein: Politico’s “Sharpton Dodges the Highlight on Newest Push to Ban Menthol Cigarettes,” by means of Julia Marsh

Sarah Karlin-Smith: Attract’s “With New Law, You Can Be expecting Extra Remembers to Hit the Good looks Business,” by means of Elizabeth Siegel and Deanna Pai

Jessie Hellmann: The New York Occasions’ “Opioid Agreement Hinders Sufferers’ Get admission to to a Broad Array of Medicine,” by means of Christina Jewett and Ellen Gabler

Additionally discussed on this week’s podcast:

Credit

Francis Ying
Audio manufacturer

Emmarie Huetteman
Editor

To listen to all our podcasts, click on right here.

And subscribe to KHN’s What the Well being? on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or anywhere you pay attention to podcasts.

This tale used to be produced by means of KHN (Kaiser Well being Information), a countrywide newsroom that produces in-depth journalism about well being problems. At the side of Coverage Research and Polling, KHN is among the 3 primary working techniques at KFF (Kaiser Circle of relatives Basis). KFF is an endowed nonprofit group offering knowledge on well being problems to the country.

KHN (Kaiser Well being Information) is a countrywide newsroom that produces in-depth journalism about well being problems. At the side of Coverage Research and Polling, KHN is among the 3 primary working techniques at KFF (Kaiser Circle of relatives Basis). KFF is an endowed nonprofit group offering knowledge on well being problems to the country.

USE OUR CONTENT

This tale can also be republished totally free (main points).

We inspire organizations to republish our content material, without cost. Right here’s what we ask:

You will have to credit score us as the unique writer, with a link to our californiahealthline.org web site. If imaginable, please come with the unique creator(s) and “California Healthline” within the byline. Please maintain the links within the tale.

It’s necessary to notice, now not the whole thing on californiahealthline.org is to be had for republishing. If a tale is categorised “All Rights Reserved,” we can’t grant permission to republish that merchandise.

Have questions? Tell us.